Nuclear Radiology: Page 47

Global imaging market to reach $35B by 2019
By AuntMinnieEurope.com staff writers
The global medical imaging equipment market will hit $35.4 billion by the year 2019, according to a new report by Transparency Market Research.
August 19, 2015
Pallas takes design proposals for reactor
By AuntMinnieEurope.com staff writers
Plans to replace the existing High Flux Reactor in Petten, the Netherlands are moving forward.
August 18, 2015
IBA divests North American subsidiary
By AuntMinnieEurope.com staff writers
Proton therapy developer Ion Beam Applications (IBA) has completed the divestiture of IBA Molecular North America to Illinois Health and Science.
August 2, 2015
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The 243.5 million euro deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The $270 million deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Perma-Fix subsidiary partners with Digirad for Tc-99m deal
By AuntMinnieEurope.com staff writers
Perma-Fix Environmental Services announced that its Polish subsidiary, Perma-Fix Medical, has finalized its partnership with nuclear medicine firm Digirad regarding technetium-99m (Tc-99m).
July 26, 2015
Blue Earth secures $28M in venture capital
By AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.
July 22, 2015
Blue Earth gets orphan drug status
By AuntMinnieEurope.com staff writers
Blue Earth Diagnostics has received two orphan drug designations for its F-18 fluciclovine radiopharmaceutical for diagnosing glioma.
July 7, 2015
Global isotope market could reach $7B by 2020
By AuntMinnieEurope.com staff writers
Widespread use of radiopharmaceutical isotopes with diagnostic equipment such as PET and SPECT systems could buoy the global nuclear medicine/radiopharmaceutical market to $7 billion by the end of the decade.
July 7, 2015
AAA signs Fuji as distributor in Japan
By AuntMinnieEurope.com staff writers
French molecular imaging firm Advanced Accelerator Applications (AAA) has signed a distribution deal for its Lutathera radiopharmaceutical with Fujifilm RI Pharma in Japan.
June 30, 2015
AAA nets $29M for new products
By AuntMinnieEurope.com staff writers
French molecular imaging firm Advanced Accelerator Applications (AAA) has garnered $28.7 million (23 million euros) in financing from U.S.-based investors.
June 24, 2015
Florbetaben-PET finds more beta-amyloid plaques
By Wayne Forrest
New research indicates that PET imaging with the radiotracer florbetaben can detect a form of beta-amyloid plaque that develops early in the brain. The findings could possibly lead to the earlier detection of Alzheimer's disease, as well as new clinical indications for florbetaben.
June 24, 2015
2015 06 18 11 46 01 878 Catafau Florbetaben 200
Previous Page
Page 47 of 90
Next Page